Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 19;26(16):7986.
doi: 10.3390/ijms26167986.

Klotho Deficiency Promotes Skeletal Muscle Weakness and Is Associated with Impaired Motor Unit Connectivity

Affiliations

Klotho Deficiency Promotes Skeletal Muscle Weakness and Is Associated with Impaired Motor Unit Connectivity

Linda A Bean et al. Int J Mol Sci. .

Abstract

Muscle wasting and weakness are critical clinical problems that limit mobility and independence, reduce health span, and increase the risk of physical disability. The molecular basis for this has not been fully determined. Klotho expression is downregulated in conditions associated with muscle wasting, including aging, chronic kidney disease, and myopathy. The objective of this study was to investigate a mechanistic role for Klotho in regulating muscle wasting and weakness. Body weight, lean mass, muscle mass, and myofiber caliber were reduced in Klotho-deficient mice. In the tibialis anterior muscle of Klotho-null mice, type IIa myofibers were resistant to changes in size, and muscle composition differed with a higher concentration of type IIb fibers to the detriment of type IIx fibers. Glycolytic GPDH enzymatic activity also increased. Klotho-deficient mice showed impaired muscle contractility, with reduced twitch force, torque, and contraction-relaxation rates. RNA sequencing revealed upregulation of synaptic and fetal sarcomeric genes, prompting us to examine muscle innervation. Klotho deficiency led to neuromuscular junction remodeling, myofiber denervation, and functional motor unit loss. Loss of motor units correlated with absolute torque. Collectively, these findings reveal a novel mechanism through which systemic Klotho deficiency disrupts muscle synapses and motor unit connectivity, potentially contributing to muscle wasting and weakness.

Keywords: Klotho; motor unit; skeletal muscle; wasting.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Klotho-deficient mice have reduced body mass, lean mass, fat mass, and muscle mass. (A) Representative images of wild-type (186 bp) and mutant (426 bp) PCR products from wild-type, heterozygous, and homozygous mice distinguish genotype. (B) Immunoblot confirms no detectable Klotho expression in kidney or muscle lysates of KL−/− mice. (C) qRT-PCR assays show Kl mRNA expression is not detectable in KL−/− muscle lysates. n = 4 per group. (D) Serum phosphate levels were characteristically increased in KL−/− mice. n = 5 per group. (E) Body mass and body composition were assessed by Echo-MRI, showing decreased lean mass and fat mass in KL−/− mice. Muscle mass (F) and muscle mass normalized to body mass (G) of the quadriceps (quad), tibialis anterior (TA), gastrocnemius (gastroc), and soleus (sol) in wild-type and KL−/− mice. n = 5–6 per group. Data are presented as mean ± SEM, with black dots showing individual data points. All p values are based on two-tailed t tests. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus wild-type.
Figure 2
Figure 2
Genetic Klotho deficiency reduces muscle fiber size and affects fiber-type composition in TA muscles. (A) (left) Mean muscle fiber cross-sectional area (CSA). n = 5 per group. p values based on two-tailed t tests. (right) Frequency distribution of muscle fiber size by CSA. (B) Quantification of muscle fiber CSA by fiber type in TA muscles from wild-type and KL−/− mice. (C) Quantification of TA muscle composition by fiber type. n = 5 per group. (D) Representative montages of whole TA cross-sections from wild-type (left) and KL−/− (right) mice immunolabeled with antibodies to laminin (blue), myosin heavy chain type (MyHC) I (magenta), MyHC IIa (green), MyHC IIb (red), and MyHC IIx unlabeled (black). Montage bar = 500 μm. Inset bar = 100 μm. n = 5 per group. Data are presented as mean ± SEM, with black dots showing individual data points. Unless otherwise indicated, p values are based on two-way ANOVA with the Šidák multiple comparison test (B-D, G-I). * p < 0.05, ** p < 0.01, **** p < 0.0001 versus wild-type.
Figure 3
Figure 3
Genetic Klotho deficiency reduces muscle fiber size in soleus muscles. (A) (left) Mean muscle fiber cross-sectional area (CSA). n = 5 per group. p values based on two-tailed t tests. (right) Frequency distribution of muscle fiber size by CSA. (B) Quantification of muscle fiber CSA by fiber type in soleus muscles from wild-type and KL−/− mice. n = 5 per group. (C) Quantification of soleus muscle composition by fiber type. n = 5 per group. (D) Representative montages of whole soleus muscle cross-sections from wild-type (left) and KL−/− (right) mice immunolabeled with antibodies to laminin (blue), myosin heavy chain type (MyHC) I (magenta), MyHC IIa (green), MyHC IIb (red), and MyHC IIx unlabeled (black). Montage bar = 250 μm. Inset bar = 50 μm. Data are presented as mean ± SEM, with black dots showing individual data points. p values are based on two-way ANOVA with the Šidák multiple comparison test (B-D, G-I). * p < 0.05, ** p < 0.01, **** p < 0.0001 versus wild-type.
Figure 4
Figure 4
Genetic ablation of Klotho increases glycolytic GPDH enzymatic activity in TA muscles. (AC) Serial cryosections of TA muscles immunolabeled for MyHC isoforms or succinate dehydrogenase (SDH) or glycerol-3-phosphate-dehydrogenase (GPDH) enzyme histochemistry. Quantification of SDH (A) and GPDH (B) optical density and GPDH-to-SDH ratio (C) by fiber type. n = 3 per group. p values based on two-way ANOVA with Tukey’s multiple comparison test. (D) Representative images of the same region of TA cross-sections. (left) Cross-sections immunolabeled for laminin (blue), MyHC I (magenta), MyHC IIa (green), MyHC IIb (red), and MyHC IIx unlabeled (black). (middle) SDH enzyme histochemistry. (right) GPDH enzyme histochemistry. Symbols indicate the following: a = type IIa, x = type IIx, and b = type IIb fiber types across images. Bar = 50 μm. (E) (left) Mean SDH enzyme activity. p values based on two-tailed t tests. (middle) Frequency distribution of SDH activity independent of fiber type. (right) Representative images of SDH activity in whole TA montages from wild-type and KL−/− mice in gray-scale. Montage bar = 500 μm. (F) (left) Mean GPDH enzyme activity. p values based on two-tailed t tests. (middle) Frequency distribution of GPDH activity independent of fiber type. Data are presented as mean ± SEM, with black dots showing individual data points. p values based on two-way ANOVA with the Šidák multiple comparison test. (right) Representative images of GPDH enzyme histochemistry of whole TA cross-section montages from wild-type and KL−/− mice in gray-scale. Montage bar = 500 μm. n = 3 per group. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus wild-type.
Figure 5
Figure 5
RNA sequencing analysis shows distinct gene expression profiles in skeletal muscles from Klotho-deficient mice. (A) Multi-dimensional scaling plot comparing TA muscles from wild-type and KL−/− mice. n = 4 per group. Black = wild-type. Blue = KL−/−. (B) A volcano plot highlighting selected differentially expressed genes (DEGs). Increased expression (red) and decreased expression (blue) in KL−/− muscles. Colored dots = abs(log20.5) fold change with FDR < 0.05. (C) A heatmap of samples showing select DEGs in WT and KL−/− muscles. Positive (red) and negative (blue) Z-scores. (D) qRT-PCR assays validating differential expression of selected sarcomeric (top), inflammatory and pro-fibrotic (bottom left), and acetylcholine receptor and neurotrophic genes (bottom right). n = 4 per group. Data are presented as mean ± SEM, with black dots showing individual data points. p values based on two-tailed t tests. * p < 0.05 versus wild-type. (E) Dot plot depicting activated (left) and suppressed (right) GO of Biological Process terms in KL−/− muscles. (F) Ridgeline plot, grouped by gene set, representing activated and suppressed KEGG pathways in KL−/− muscles.
Figure 6
Figure 6
Muscle contractile function is impaired in Klotho-deficient mice. In vivo plantar flexion force assessment of the triceps surae muscle group in WT and KL−/− mice is reported as follows: (A) absolute twitch (mN·m), twitch normalized to body weight (mN·m per g body weight), twitch max rate of contraction and relaxation, and representative max twitch trace; (B) absolute torque (mN·m), tetanic torque normalized to body weight (mN·m per g body weight), max torque rate of contraction and relaxation, and representative max torque trace. n = 5–6 per group. Data are presented as mean ± SEM, with black dots showing individual data points. All p values are based on two-tailed t tests. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus wild-type.
Figure 7
Figure 7
Genetic Klotho deficiency alters single motor unit potential (SMUP) and motor unit number estimation (MUNE). (A) Compound muscle action potential (CMAP; millivolts (mV)). Representative trace of CMAP in WT and KL−/−. (B) SMUP (microvolts (μV)). Representative incremental traces of SMUP in WT and KL−/−. (C) MUNE (number of motor units (#)). (D) In vivo plantar flexion absolute torque correlated with MUNE. n = 5–6 per group. Data are presented as mean ± SEM, with black dots showing individual data points. All p values are based on two-tailed t tests (AC) or correlation analysis for Pearson r values. ** p < 0.01 versus wild-type.
Figure 8
Figure 8
Genetic ablation of Klotho increases the concentration of denervated muscle fibers, reduces synaptic contact, and alters NMJ morphology in TA muscles. (A) Myonuclei number per muscle fiber. n = 5 per group. Representative image of a muscle cross-section immunolabeled with dystrophin and stained with DAPI to visualize nuclei for quantification of myonuclei. Arrows = myonuclei. Arrowheads = interstitial nuclei. Bar = 20 μm. (B) Serum creatine kinase (CK) levels. n = 5 per group. (C) Quantification of the percentage of muscle fibers with centrally located nuclei to total muscle fibers. n = 5 per group. Representative image of a muscle cross-section immunolabeled with dystrophin and stained with DAPI to quantify centrally nucleated fibers (CNFs). Arrow = CNF. Bar = 50 μm. (D) Quantification of the proportion of denervated muscle fibers expressing NCAM. n = 5 per group. Representative images of muscle sections immunolabeled with dystrophin (red) and NCAM (green) from wild-type (left) and KL−/− mice (right). Arrowhead = NMJ with high expression of NCAM. Arrow = small angulated denervated fiber with high cytosolic expression of NCAM. Bar = 50 μm. (E) Quantification of NMJ morphological properties of longitudinal sections of TA muscles from wild-type and KL−/− mice. Percent co-localization of synaptic vesicles and AChRs; post-synaptic NMJ morphology endplate area, AChR area, compactness (AChR area/endplate area), and number of AChR fragments; and pre-synaptic NMJ morphology axon diameter, nerve terminal area, number of terminal branches, and branch points. In dispersion plots, each point represents a single NMJ from n = 5 wild-types and n = 6 KL−/− biological replicates, with n = 6–15 en face NMJs quantified per biological replicate. (F) Representative images of longitudinally cut TA muscle sections from wild-type (top) and KL−/− mice (bottom) stained with bungarotoxin (red) and immunolabeled with SV2 and neurofilament (green). Bar = 20 μm. Data are presented as mean ± SEM, with black dots showing individual data points. All p values are based on two-tailed t tests. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus wild-type.

Update of

References

    1. Fukagawa N.K., Wolfson L., Judge J., Whipple R., King M. Strength is a major factor in balance, gait, and the occurrence of falls. J. Gerontol. A Biol. Sci. Med. Sci. 1995;50A:64–67. doi: 10.1093/gerona/50A.Special_Issue.64. - DOI - PubMed
    1. Tinetti M.E., Williams C.S. Falls, injuries due to falls, and the risk of admission to a nursing home. N. Engl. J. Med. 1997;337:1279–1284. doi: 10.1056/NEJM199710303371806. - DOI - PubMed
    1. Liu C.K., Lyass A., Massaro J.M., D’Agostino R.B., Sr., Fox C.S., Murabito J.M. Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: The Framingham Offspring Study. J. Gerontol. A Biol. Sci. Med. Sci. 2014;69:301–307. doi: 10.1093/gerona/glt096. - DOI - PMC - PubMed
    1. Mayer K.P., Thompson Bastin M.L., Montgomery-Yates A.A., Pastva A.M., Dupont-Versteegden E.E., Parry S.M., Morris P.E. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit. Care. 2020;24:637. doi: 10.1186/s13054-020-03355-x. - DOI - PMC - PubMed
    1. Baskin K.K., Winders B.R., Olson E.N. Muscle as a “mediator” of systemic metabolism. Cell Metab. 2015;21:237–248. doi: 10.1016/j.cmet.2014.12.021. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources